# NWRD09 for Persistent Cervical HPV16 Infection

> **NCT07710703** · NA · RECRUITING · sponsor: **Newish Biotech (Wuxi) Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Persistent Cervical HPV16 Infection

## Interventions

- **BIOLOGICAL:** NWRD09/ Placebo administered by IM injection

## Key facts

- **NCT ID:** NCT07710703
- **Lead sponsor:** Newish Biotech (Wuxi) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-10
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07710703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07710703, "NWRD09 for Persistent Cervical HPV16 Infection". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07710703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*